市場調查報告書

全球細胞治療技術市場規模調查:各產品、流程、細胞類型、終端用戶,及各地區預測 2019年-2026年

Global Cell therapy Technologies Market Size study, by Product, Process, Cell Type, End User and Regional Forecasts 2019-2026

出版商 Bizwit Research & Consulting LLP 商品編碼 888729
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
Back to Top
全球細胞治療技術市場規模調查:各產品、流程、細胞類型、終端用戶,及各地區預測 2019年-2026年 Global Cell therapy Technologies Market Size study, by Product, Process, Cell Type, End User and Regional Forecasts 2019-2026
出版日期: 2019年07月10日內容資訊: 英文
簡介

本報告提供全球細胞治療技術市場的相關調查,市場趨勢和機會,成長要素和課題,各產品、流程、細胞類型、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 摘要整理

  • 市場概述
  • 主要趨勢
  • 整體及各分類市場預測
    • 實行各類型
    • 檢測各技術
    • 細胞的各類型
    • 各終端用戶
    • 各地區
  • 調查方法
  • 調查的前提條件

第2章 全球細胞治療技術市場定義和範圍

  • 研究的目的
  • 市場定義和範圍
    • 產業的演進
    • 調查範圍
  • 研究考慮年份
  • 匯率

第3章 全球細胞治療技術的市場動態

  • Seesaw分析
    • 市場成長要素
    • 市場課題
    • 市場機會

第4章 全球細胞治療技術市場產業分析

  • 波特的五力分析
    • 買主談判力
    • 供應商談判力
    • 新加入廠商的威脅
    • 替代品的威脅
    • 產業內的競爭
    • 波特的五力分析的未來的方法
  • PEST分析
    • 政治
    • 經濟
    • 社會
    • 技術
  • 主要的購買標準(按需)
  • 法律規範(按需)
  • 投資/引進方案(按需)
  • 分析師的建議與結論

第5章 全球細胞治療技術市場:各產品

  • 市場概述
  • 市場成果 - 潛在模式
  • 細胞治療技術市場,子區隔分析
    • 消耗品
    • 設備
    • 系統及軟體

第6章 全球細胞治療技術市場:各流程

  • 市場概述
  • 市場成果 - 潛在模式
  • 細胞治療技術市場,子區隔分析
    • 細胞處理
    • 細胞的保存,流通,及出貨
    • 流程的監視和品管

第7章 全球細胞治療技術市場:各細胞類型

  • 市場概述
  • 市場成果 - 潛在模式
  • 細胞治療技術市場,子區隔分析
    • 人細胞
    • 動物細胞

第8章 全球細胞療法技術市場:各終端用戶

  • 市場概述
  • 市場成果 - 潛在模式
  • 細胞治療技術市場,子區隔分析
    • 生命科學研究企業
    • 研究機關

第9章 全球細胞治療技術市場:各地區

  • 細胞治療技術市場,地區市場概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他
  • 南美
    • 巴西
    • 墨西哥
  • 其他
    • 中東及非洲

第10章 競爭情形

  • 企業的市場佔有率(資料的各可得性)
  • 前幾名企業的市場策略
  • 企業簡介
    • Thermo Fisher Scientific, Inc.
    • Merck KGaA
    • Terumo Bct, Inc.(Terumo Corporation)
    • Lonza Group
    • Ge Healhcare
    • Sartorius
    • Becton, Dickinson and Company
    • Beckman Coulter, Inc.
    • Miltenyi Biotec GmbH
    • Stemcell Technologies

第11章 調查方法

  • 調查方法
    • 資料探勘
    • 分析
    • 市場預測
    • 檢驗
    • 出版
    • 調查的前提條件
目錄

Global Cell therapy Technologies is valued approximately USD 10.2 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 14.4% over the forecast period 2019-2026. Cell therapy refers to the biological activities carried out by cells that would lead to a desired effect either in vivo or in vitro. In cell therapy, cell suspensions enter into an organ or tissue or the blood stream with the possibility that these cells would be able to heal any injury. The main aim of cell therapy is to target various diseases at the cellular level by restoring a certain cell population as carriers of therapeutic cargo. cell therapy can be used for the treatment of a variety of diseases including treatment of cancers, urinary problems, autoimmune disease, and infectious disease, repairing spinal cord injuries, rebuilding damaged cartilage in joints, improving the immune system, and treatment of neurological disorders.Rising funding from government as well as private organizations to support cell therapy clinical trials has increased the demand of this market. Additionally, introduction of effective guidelines for cell therapy manufacturing, and proven effectiveness of products driven the growth of Cell Therapy Market over the forecast period of 2019-2026.

The regional analysis of global Cell therapy Technologies is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. The North America is the leading region across the world. The implementation of stringent regulations and increasing R&D activities in the pharmaceutical and biotechnology industries are the key drivers for market growth in this region.

Major market player included in this report are:

  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Terumo Bct, Inc.
  • Lonza Group
  • Ge Healhcare
  • Sartorius
  • Becton, Dickinson and Company
  • Beckman Coulter, Inc.
  • Miltenyi Biotec GmbH
  • Stemcell Technologies

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

  • Consumables
  • Equipment
  • Systems & Software

By Process:

  • Cell Processing
  • Cell prevention
  • Distribution, and Handling

By Cell Type:

  • Human Cells
  • Animal Cells
  • By End User:
  • Life Science Research Companies
  • Research Institutes

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • Asia Pacific
  • China
  • India
  • Japan
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

  • Historical year - 2016, 2017
  • Base year - 2018
  • Forecast period - 2019 to 2026

Target Audience of the Global Cell therapy Technologies in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

Table of Contents

Chapter 1.Executive Summary

  • 1.1.Market Snapshot
  • 1.2.Key Trends
  • 1.3.Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
    • 1.3.1.Cell Therapy Technologies Market, by Implementation Type, 2016-2026 (USD Billion)
    • 1.3.2.Cell Therapy Technologies Market, by Measurement Technology, 2016-2026 (USD Billion)
    • 1.3.3.Cell Therapy Technologies Market, by Cell Type, 2016-2026 (USD Billion)
    • 1.3.4.Cell Therapy Technologies Market, by End User, 2016-2026 (USD Billion)
    • 1.3.5.Cell Therapy Technologies Market, by Region, 2016-2026 (USD Billion)
  • 1.4.Estimation Methodology
  • 1.5.Research Assumption

Chapter 2.Global Cell Therapy Technologies Market Definition and Scope

  • 2.1.Objective of the Study
  • 2.2.Market Definition & Scope
    • 2.2.1.Industry Evolution
    • 2.2.2.Scope of the Study
  • 2.3.Years Considered for the Study
  • 2.4.Currency Conversion Rates

Chapter 3.Global Cell Therapy Technologies Market Dynamics

  • 3.1.See Saw Analysis
    • 3.1.1.Market Drivers
    • 3.1.2.Market Challenges
    • 3.1.3.Market Opportunities

Chapter 4.Global Cell Therapy Technologies Market Industry Analysis

  • 4.1.Porter's 5 Force Model
    • 4.1.1.Bargaining Power of Buyers
    • 4.1.2.Bargaining Power of Suppliers
    • 4.1.3.Threat of New Entrants
    • 4.1.4.Threat of Substitutes
    • 4.1.5.Competitive Rivalry
    • 4.1.6.Futuristic Approach to Porter's 5 Force Model
  • 4.2.PEST Analysis
    • 4.2.1.Political Scenario
    • 4.2.2.Economic Scenario
    • 4.2.3.Social Scenario
    • 4.2.4.Technological Scenario
  • 4.3.Key Buying Criteria (On Demand)
  • 4.4.Regulatory Framework (On Demand)
  • 4.5.Investment Vs Adoption Scenario (On Demand)
  • 4.6.Analyst Recommendation & Conclusion

Chapter 5.Global Cell Therapy Technologies Market, by Product

  • 5.1.Market Snapshot
  • 5.2.Market Performance - Potential Model
  • 5.3.Cell Therapy Technologies Market, Sub Segment Analysis
    • 5.3.1. Consumables
      • 5.3.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.3.1.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.3.2. Equipment
      • 5.3.2.1.Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.3.2.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 5.3.2.3.Market sub segment
        • 5.3.2.3.1.Cell Processing Equipment
        • 5.3.2.3.2.Single-Use Equipment
        • 5.3.2.3.3.Other Equipment
    • 5.3.3. Systems & Software
      • 5.3.3.1.Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.3.3.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 6.Global Cell Therapy Technologies Market, by Process

  • 6.1.Market Snapshot
  • 6.2.Market Performance - Potential Model
  • 6.3.Cell Therapy Technologies Market, Sub Segment Analysis
    • 6.3.1. Cell Processing
      • 6.3.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.3.1.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.3.2. Cell Preservation, Distribution, and Handling
      • 6.3.2.1.Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.3.2.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.3.3.Process Monitoring and Quality Control
      • 6.3.3.1.Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.3.3.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 7.Global Cell Therapy Technologies Market, by Cell Type

  • 7.1.Market Snapshot
  • 7.2.Market Performance - Potential Model
  • 7.3.Cell Therapy Technologies Market, Sub Segment Analysis
    • 7.3.1. Human Cells
      • 7.3.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.3.1.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 7.3.1.3.Market Sub Segment
        • 7.3.1.3.1.Stem Cells
        • 7.3.1.3.2.Differentiated Cells
    • 7.3.2. Animal Cells
      • 7.3.2.1.Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.3.2.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 8.Global Cell Therapy Technologies Market, by End-User

  • 8.1.Market Snapshot
  • 8.2.Market Performance - Potential Model
  • 8.3.Cell Therapy Technologies Market, Sub Segment Analysis
    • 8.3.1. Life Science Research Companies
      • 8.3.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.1.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.3.2. Research Institutes
      • 8.3.2.1.Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.2.2.Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 9.Global Cell Therapy Technologies Market, by Regional Analysis

  • 9.1.Cell Therapy Technologies Market, Regional Market Snapshot (2016-2026)
  • 9.2.North America Cell Therapy Technologies Market Snapshot
    • 9.2.1.U.S.
      • 9.2.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.2.1.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.2.1.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.2.1.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.2.1.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 9.2.2.Canada
      • 9.2.2.1.Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.2.2.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.2.2.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.2.2.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.2.2.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 9.3.Europe Cell Therapy Technologies Market Snapshot
    • 9.3.1.U.K.
      • 9.3.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.1.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.1.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.1.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.1.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.1.6.
    • 9.3.2.Rest of Europe
      • 9.3.2.1.Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.2.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.2.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.2.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.2.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 9.4.Asia Cell Therapy Technologies Market Snapshot
    • 9.4.1.China
      • 9.4.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.1.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.1.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.1.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.1.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 9.4.2.India
      • 9.4.2.1.Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.2.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.2.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.2.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.2.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 9.4.3.Japan
      • 9.4.3.1.Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.3.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.3.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.3.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.3.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 9.4.4.Rest of Asia Pacific
      • 9.4.4.1.Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.4.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.4.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.4.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.4.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 9.5.Latin America Cell Therapy Technologies Market Snapshot
    • 9.5.1.Brazil
      • 9.5.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.5.1.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.5.1.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.5.1.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.5.1.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 9.5.2.Mexico
      • 9.5.2.1.Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.5.2.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.5.2.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.5.2.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.5.2.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 9.6.Rest of The World
    • 9.6.1.Middle East and Africa
      • 9.6.1.1.Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.6.1.2. Product breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.6.1.3. Process breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.6.1.4.Cell Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.6.1.5.End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 10.Competitive Intelligence

  • 10.1.Company Market Share (Subject to Data Availability)
  • 10.2.Top Market Strategies
  • 10.3.Company Profiles
    • 10.3.1. Thermo Fisher Scientific, Inc.
      • 10.3.1.1.Overview
      • 10.3.1.2.Financial (Subject to Data Availability)
      • 10.3.1.3.Product Summary
      • 10.3.1.4.Recent Developments
    • 10.3.2. Merck KGaA
    • 10.3.3.Terumo Bct, Inc.
    • 10.3.4.Lonza Group
    • 10.3.5.Ge Healhcare
    • 10.3.6.Sartorius
    • 10.3.7.Becton, Dickinson and Company
    • 10.3.8.Beckman Coulter, Inc.
    • 10.3.9.Miltenyi Biotec GmbH
    • 10.3.10.Stemcell Technologies

Chapter 11.Research Process

  • 11.1.Research Process
    • 11.1.1.Data Mining
    • 11.1.2.Analysis
    • 11.1.3.Market Estimation
    • 11.1.4.Validation
    • 11.1.5.Publishing
    • 11.1.6.Research Assumption

List of Tables

  • TABLE 1.LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL CELL THERAPY TECHNOLOGIES MARKET
  • TABLE 2.LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL CELL THERAPY TECHNOLOGIES MARKET
  • TABLE 3.GLOBAL CELL THERAPY TECHNOLOGIES MARKET, REPORT SCOPE
  • TABLE 4.YEARS CONSIDERED FOR THE STUDY
  • TABLE 5.EXCHANGE RATES CONSIDERED
  • TABLE 6.GLOBAL CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
  • TABLE 7.GLOBAL CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY PRODUCT2016-2026 (USD BILLION)
  • TABLE 8.GLOBAL CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY PROCESS2016-2026 (USD BILLION)
  • TABLE 9.GLOBAL CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY CELL TYPE 2016-2026 (USD BILLION)
  • TABLE 10.GLOBAL CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD BILLION)
  • TABLE 11.GLOBAL CELL THERAPY TECHNOLOGIES MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 12.GLOBAL CELL THERAPY TECHNOLOGIES MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 13.GLOBAL CELL THERAPY TECHNOLOGIES MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 14.GLOBAL CELL THERAPY TECHNOLOGIES MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 15.GLOBAL CELL THERAPY TECHNOLOGIES MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 16.GLOBAL CELL THERAPY TECHNOLOGIES MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 17.GLOBAL CELL THERAPY TECHNOLOGIES MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 18.GLOBAL CELL THERAPY TECHNOLOGIES MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 19.GLOBAL CELL THERAPY TECHNOLOGIES MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 20.GLOBAL CELL THERAPY TECHNOLOGIES MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 21.GLOBAL CELL THERAPY TECHNOLOGIES MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 22.GLOBAL CELL THERAPY TECHNOLOGIES MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 23.GLOBAL CELL THERAPY TECHNOLOGIES MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 24.GLOBAL CELL THERAPY TECHNOLOGIES MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 25. GLOBAL CELL THERAPY TECHNOLOGIES MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 26.GLOBAL CELL THERAPY TECHNOLOGIES MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 27.GLOBAL CELL THERAPY TECHNOLOGIES MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 28.GLOBAL CELL THERAPY TECHNOLOGIES MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 29.GLOBAL CELL THERAPY TECHNOLOGIES MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 30.GLOBAL CELL THERAPY TECHNOLOGIES MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 31.U.S. CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 32.U.S. CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 33.U.S. CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 34.U.S. CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 35.U.S. CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 36.CANADA CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 37.CANADA CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 38.CANADA CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 39.CANADA CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 40.CANADA CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 41.UK CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 42.UK CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 43.UK CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 44.UK CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 45.UK CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 46.GERMANY CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 47.GERMANY CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 48.GERMANY CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 49.GERMANY CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 50.GERMANY CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 51.ROE CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 52.ROE CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 53.ROE CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 54.ROE CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 55.ROE CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 56.CHINA CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 57.CHINA CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 58.CHINA CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 59.CHINA CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 60.CHINA CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 61.INDIA CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 62.INDIA CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 63.INDIA CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 64.INDIA CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 65.INDIA CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 66.JAPAN CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 67.JAPAN CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 68.JAPAN CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 69.JAPAN CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 70.JAPAN CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 71.ROAPAC CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 72.ROAPAC CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 73.ROAPAC CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 74.ROAPAC CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 75.ROAPAC CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 76.BRAZIL CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 77.BRAZIL CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 78.BRAZIL CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 79.BRAZIL CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 80.BRAZIL CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 81.MEXICO CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 82.MEXICO CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 83.MEXICO CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 84.MEXICO CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 85.MEXICO CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 86.ROLA CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 87.ROLA CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 88.ROLA CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 89.ROLA CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 90.ROLA CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 91.ROW CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 92.ROW CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 93.ROW CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 94.ROW CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 95.ROW CELL THERAPY TECHNOLOGIES MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

List of Figures

  • FIG 1.GLOBAL CELL THERAPY TECHNOLOGIES MARKET, RESEARCH METHODOLOGY
  • FIG 2.GLOBAL CELL THERAPY TECHNOLOGIES MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3.GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4.GLOBAL CELL THERAPY TECHNOLOGIES MARKET, KEY TRENDS 2017
  • FIG 5.GLOBAL CELL THERAPY TECHNOLOGIES MARKET, GROWTH PROSPECTS 2018-2026
  • FIG 6.GLOBAL CELL THERAPY TECHNOLOGIES MARKET, PORTERS 5 FORCE MODEL
  • FIG 7.GLOBAL CELL THERAPY TECHNOLOGIES MARKET, PEST ANALYSIS
  • FIG 8.GLOBAL CELL THERAPY TECHNOLOGIES MARKET, VALUE CHAIN ANALYSIS
  • FIG 9.GLOBAL CELL THERAPY TECHNOLOGIES MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 10.GLOBAL CELL THERAPY TECHNOLOGIES MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 11.GLOBAL CELL THERAPY TECHNOLOGIES MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 12.GLOBAL CELL THERAPY TECHNOLOGIES MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 13.GLOBAL CELL THERAPY TECHNOLOGIES MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 14.GLOBAL CELL THERAPY TECHNOLOGIES MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 15.GLOBAL CELL THERAPY TECHNOLOGIES MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 16.GLOBAL CELL THERAPY TECHNOLOGIES MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 17.GLOBAL CELL THERAPY TECHNOLOGIES MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 18.GLOBAL CELL THERAPY TECHNOLOGIES MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 19.GLOBAL CELL THERAPY TECHNOLOGIES MARKET, REGIONAL SNAPSHOT 2016 & 2026
  • FIG 20.NORTH AMERICA CELL THERAPY TECHNOLOGIES MARKET 2016 & 2026 (USD BILLION)
  • FIG 21.EUROPE CELL THERAPY TECHNOLOGIES MARKET 2016 & 2026 (USD BILLION)
  • FIG 22.ASIA PACIFIC CELL THERAPY TECHNOLOGIES MARKET 2016 & 2026 (USD BILLION)
  • FIG 23.LATIN AMERICA CELL THERAPY TECHNOLOGIES MARKET 2016 & 2026 (USD BILLION)
  • FIG 24.GLOBAL CELL THERAPY TECHNOLOGIES MARKET, COMPANY MARKET SHARE ANALYSIS (2016)
Back to Top